Skip to main content

Shares of Johnson & Johnson (JNJ) - Get Johnson & Johnson Report rose in after-hours trading Tuesday after the company released results of 15 new tests from the same bottle of Johnson's Baby Powder previously tested by the FDA that found no asbestos.

An additional 48 laboratory tests were conducted on samples from the single lot of Johnson's Baby Powder that was voluntarily recalled on Oct. 18. Shares fell more than 6% that day.

Shares rose $4.88, or 3.8%, to $134 in after-hours trading.

Scroll to Continue

TheStreet Recommends

Johnson & Johnson faces thousands of lawsuits alleging its iconic baby powder caused cancer in women who used the product.

Johnson & Johnson is a holding in Jim Cramer's Action Alerts PLUS member club.

Save 57% during our Halloween Sale. Don't let this market haunt you. Join Jim Cramer's Investment Club, Action Alerts PLUS. Click here to sign up!